GH1 and breast cancer: In mammary tumor cells, GH and GHR may be co-expressed, resulting in the autocrine intracellular activation of the GH/GHR system [2,6], which is inaccessible for drugs that only compete for the GH/GHR interaction at the cell surface [10].